Diabetes Management in End of Life: A Preliminary Report Stemming From Clinical Experience. (September 2015)

• Record Type: Journal Article
• Authors: Dionisio, R.; Giardini, A.; De Cata, P.; Pirali, B.; Rossi, S.; Negri, E. M.; Ferrari, P.; Preti, P.
• Is Part Of: American journal of hospice & palliative care. Volume 32:Number 6(2015)
• Page Start: 588
• Page End: 593
• Publication Date: 2015-09
• Subjects: diabetes management -- palliative care -- cancer -- personalized antidiabetic therapy -- end of life; Hospice care -- Periodicals; Palliative treatment -- Periodicals; 362.175
• DOI: 10.1177/1049909114533140
• Languages: English
• ISSNs: 1049-9091

Abstract

The increasing coexistence of cancer and diabetes within the elderly population requires specific palliative care skills on diabetes treatment. We report our experience of diabetes management in a palliative care setting. In our retrospective 3-year activity sample (n = 563), 27.2% of patients have a diagnosis of diabetes mellitus: 80% have cancer whereas 20% have a main diagnosis of other severe chronic diseases. As to the presence/absence of diabetes, no differences emerge in the examined clinical indicators and global survival, with the exception of body mass index and days of hospitalization. At lifetime analysis, Barthel index and palliative prognostic index are the only parameters significantly related to death. Even if diabetes seems not to modify the prognosis, it significantly influences the health care burden and the team engagement.